1st Quarter - Report

PODESTA GROUP, INC. for GENZYME

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

H.R. 1249 / S. 23, America Invents Act.

LobbyistCovered position, as disclosed
SHARON COHEN —
ANNE MARIE POLAK —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 23 (112th), H.R. 1249 (112th)

Health Issues HCR

Patient Protection and Affordable Care Act implementation.

LobbyistCovered position, as disclosed
SHARON COHEN —
ANNE MARIE POLAK —
THOMAS B SPARKMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Medicare issues related to end stage renal disease.

LobbyistCovered position, as disclosed
SHARON COHEN —
ANTHONY PODESTA —
ANNE MARIE POLAK —
OSCAR RAMIREZ —
THOMAS B SPARKMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

FY 2011 and 2012 budget appropriations.

LobbyistCovered position, as disclosed
SHARON COHEN —
THOMAS B SPARKMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Prescription Drug User Fee Act reauthorization.

LobbyistCovered position, as disclosed
SHARON COHEN —
THOMAS B SPARKMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.